Effect of angiotensin peptides on PAI-1 expression and production in human adipocytes

Hormone and Metabolic Research

Volumn 33, Issue 4, 2001, Pages 196-200

  Skurk, T ^a   Lee, Y M ^a   Rohrig K ^a   Hauner, H ^a  

^a LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

Author keywords

Adipose tissue; Angiotensin II; Fibrinolysis; Hypertension; Obesity; Plasminogen activator inhibitor 1; Renin angiotensin system

Indexed keywords

ANGIOTENSIN; MESSENGER RNA; PEPTIDE; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADIPOCYTE; ARTICLE; CELL PROLIFERATION; CONCENTRATION RESPONSE; FEMALE; FIBRINOLYSIS; HUMAN; HUMAN CELL; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN SYNTHESIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK ASSESSMENT; THROMBOEMBOLISM;

ADIPOCYTES; ADULT; ANGIOTENSIN II; ANGIOTENSIN III; CELLS, CULTURED; FEMALE; FIBRINOLYSIS; GENE EXPRESSION; HUMANS; HYPERTENSION; MIDDLE AGED; OBESITY; PLASMINOGEN ACTIVATOR INHIBITOR 1; RENIN-ANGIOTENSIN SYSTEM;

EID: 0035010574     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-14948     Document Type: Article

References (29)

1. Vaughan DE. The renin-angiotensin-system and fibrinolysis. Am J Cardiol 1997; 79: 2-14
2. Karlsson C, Lindell K, Ottosson M, Sjöström L, Carlsson B, Carlsson LM. Human adipose tissue expresses angiotensinogen and enzymes required for its conversion to angiotensin II. J Clin Endocrinol Metab 1998; 83: 3925-3929
3. Schling P, Mallow H, Trindl A, Löffler G. Evidence for a local renin angiotensin system in primary cultured human preadipocytes. Int J Obes Relat Metab Disord 1999; 23: 36-41
4. Engeli S, Gorzelniak K, Kreutz R, Runkel N, Distler A, Sharma AM. Co-expression of renin-angiotensin system genes in human adipose tissue. J Hypertens 1999; 17: 555-560
5. Van Harmelen V, Ariapart P, Hoffstedt J, Lundkvist I, Bringman S, Arner P. Increased adipose angiotensinogen gene expression in human obesity. Obes Res 2000; 8: 337-341
6. Van Harmelen V, Elizalde M, Ariapart P, Bergstedt-Lindqvist S, Reynisdottir S, Hoffstedt J, Lundkvist I, Bringman S, Arner P. The assotiation of human adipose angiotensinogen gene expression with abdominal fat distribution in obesity. Int J Obes Relat Metab Disord 2000; 24: 673-678
7. Hall JE, Brands MW, Henegar JR. Mechanisms of hypertension and kidney disease in obesity. Ann N Y Acad Sci 1999; 892: 91-107
8. Umemura S, Nyui N, Tamura K, Hibi K, Yamaguchi S, Nakamaru M, Ishigami T, Yabana M, Kihara M, Inoue S, Ishii M. Plasma angiotensinogen concentrations in obese patients. Am J Hypertens 1997; 10: 629-633
9. Juhan-Vague I, Alessi MC. PAI-1, obesity, insulin resistance and risk of cardiovascular events. Thromb Haemost 1997; 78: 1716-1722
10. Juhan-Vague J, Alessi MC. Fibrinolysis and risk of coronary artery disease. Fibrinolysis 1996; 10: 127-136
11. Alessi MC, Peiretti F, Morange P, Henry M, Nalbone G, Juhan-Vague I. Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease. Diabetes 1997; 46: 860-867
12. Eriksson P, Reynisdottir S, Lönnqvist F, Stemme V, Hamsten A, Arner P. Adipose tissue secretion of plasminogen activator inhibitor-1 in non-obese and obese individuals. Diabetologia 1998; 41: 65-71
13. Gottschling-Zeller H, Birgel M, Röhrig K, Hauner H. Effect of tumor necrosis factor alpha and transforming growth factor beta 1 on plasminogen activator inhibitor-1 secretion from subcutaneous and omental human fat cells in suspension culture. Metabolism 2000; 49: 666-671
14. Loskutoff DJ, Samad F. The adipocyte and hemostatic balance in obesity: studies on PAI-1. Arterioscler Thromb Vasc Biol 1998; 18: 1-6
15. Ridker PM, Caboury CL, Conlin PR, Seely EW, Williams CH, Vaughan ED. Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II. Circulation 1993; 87: 1969-1973
16. Feener EP, Northrup JM, Aiello LP, King GL. Angiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cells. J Clin Invest 1995; 95: 1353-1362
17. Vaughan DE, Lazos SA, Tong K. Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. A potential link between the renin-angiotensin system and thrombosis. J Clin Invest 1995; 95: 995-1001
18. Nishimura H, Tsuji H, Masuda H, Kasahara T, Yoshizumi M, Sugano T, Kimura S, Kawano H, Kunieda Y, Yano S, Nakagawa K, Kitamura H, Nakahara Y, Sawada S, Nakagawa M. The effects of angiotensin metabolites on the regulation of coagulation and fibrinolysis in cultured rat aortic endothelial cells. Thromb Haemost 1999; 82: 1516-1521
19. Kerins DM, Hao Q, Vaughan DE. An Angiotensin induction of PAI-1 expression in endothelial cells is mediated by the hexapeptide angiotensin IV. J Clin Invest 1995; 96: 2515-2520
20. Swanson GN, Hanesworth JM, Sardinia MF, Coleman JKM, Wright JW, Hall KL, Miller-Wing AV, Stobb JW, Cook VI, Harding EC, Harding JW. Discovery of a distinct binding site for angiotensin II (3-8). Regul Pept 1992; 40: 409-419
21. Perodin J, Bouley R, Escher E, Assimomytis N, Magafa V, Maness-Zoupa E, Theodoropoulos D, Cordopatis P. Angiotensin II analogues with sulphur-containing side-chains in position 5. A structure-activity relationship study. Arzneimittelforschung 2000; 50: 526-529
22. Skurk T, Lee Y.-M., Röhrig K, Hauner H. Angiotensin II and its metabolites stimulate PAI-1 protein release from human adipocytes in primary culture. Hypertension; manuscript accepted for publication
23. 7]-angiotensin III, a new selctive antagonist of the pressor effect of angiotensin III in conscious rats. Life Sci 1988; 43: 537-543
24. A Hauner H, Entenmann G, Wabitsch M, Gaillard D, Ailhaud G, Negrel R, Pfeiffer EF. Promoting effects of glucocorticoids on the differentiation of human adipocyte precursor cells cultured in a chemically defined medium. J Clin Invest 1989; 84: 1663-1670
25. Labinjoh C, Newby DE, Dawson P, Johnston NR, Ludlam CA, Boon NA, Webb DJ. Fibrinolytic actions of intra-arterial angiotensin II and bradykinin in vivo in man. Cardiovasc Res 2000; 47: 707-714
26. Birgel M, Gottschling-Zeller H, Röhrig K, Hauner H. Role of cytokines in the regulation of plasminogen activator inhibitor-1 expression and secretion in newly differentiated subcutaneous human adipocytes. Arterioscler Thromb Vasc Biol 2000; 20: 1682-1687
27. Bloem LJ, Manatunga AK, Tewksbury DA, Pratt HJ. The serum angiotensinogen concentration and variants of the angiotensinogen gene in white and black children. J Clin Invest 1995; 95: 948-953
28. Crandall DL, Herzlinger HE, Saunders BD, Armellino DC, Kral JG. Distribution of angiotensin II receptors in rat and human adipocytes. J Lipid Res 1994; 35: 1378-1385
29. Vaughan DE, Rouleau JL, Ridker PM, Arnold JM, Menapace FJ, Pfeffer MA. Effects of ramipril on plasma fibrinolytic balance in patients with acute anterior myocardial infarction. HEART Study Investigators. Circulation 1997; 96: 442-447